Saif, Muhammad. “MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients With Gemcitabine Refractory Metastatic Pancreatic Cancer”. JOP. Journal of the Pancreas 15, no. 3 (May 27, 2014): 278-279. Accessed May 8, 2024. http://www.serena.unina.it/index.php/jop/article/view/2507.